NASDAQ: AVIR
Atea Pharmaceuticals Inc Stock Ownership - Who owns Atea Pharmaceuticals?

Insider buying vs selling

Have Atea Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Polly A. MurphyDirector2026-05-186,100$4.17
$25.44kBuy
Andrea CorcoranChief Financial Officer Executive Vice President Legal and Secretary2026-03-1160,000$1.24
$74.40kBuy
Jeanpierre SommadossiPresident CEO and Chairman2026-02-03300,000$1.24
$372.00kBuy
Maria Arantxa HorgaChief Medical Officer2026-01-3116,073$4.24
$68.15kSell
Jeanpierre SommadossiPresident CEO and Chairman2026-01-31106,093$4.24
$449.83kSell
Andrea CorcoranChief Financial Officer Executive Vice President Legal and Secretary2026-01-3116,104$4.24
$68.28kSell
John VavrickaChief Commercial Officer2026-01-3111,570$4.24
$49.06kSell
Wayne FosterEVP Chief Accounting Officer2026-01-3112,132$4.24
$51.44kSell
Janet Mj HammondChief Development Officer2026-01-3114,136$4.24
$59.94kSell

1 of 1

AVIR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVIR insiders and whales buy or sell their stock.

AVIR Shareholders

What type of owners hold Atea Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Jeanpierre Sommadossi8.27%6,633,855$35.03MInsider
Cormorant Asset Management LP7.99%6,411,355$33.85MInsider
Andrew A. F. Hack7.00%5,615,659$29.65MInsider
Chung K. Chu1.47%1,176,862$6.21MInsider
Andrea Corcoran1.03%823,576$4.35MInsider
Curated Wealth Partners LLC0.87%695,000$3.67MInstitution
Franklin M. Berger0.67%536,097$2.83MInsider
Rock Springs Capital Management LP0.36%289,695$1.53MInsider
John Vavricka0.21%165,102$871.74kInsider
Bruno Lucidi0.18%142,350$751.61kInsider

1 of 3

AVIR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVIR0.07%28.16%Net Buying
LRMR0.09%66.77%Net BuyingNet Buying
XFOR0.10%7.96%Net SellingNet Selling
PROK0.02%39.28%Net Selling
CMPX0.09%22.93%Net Buying

Atea Pharmaceuticals Stock Ownership FAQ

Who owns Atea Pharmaceuticals?

Atea Pharmaceuticals (NASDAQ: AVIR) is owned by 0.07% institutional shareholders, 28.16% Atea Pharmaceuticals insiders, and 71.77% retail investors. Jeanpierre Sommadossi is the largest individual Atea Pharmaceuticals shareholder, owning 6.63M shares representing 8.27% of the company. Jeanpierre Sommadossi's Atea Pharmaceuticals shares are currently valued at $35.03M.

If you're new to stock investing, here's how to buy Atea Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.